Week In Review: Beigene Sets Record With $1.4 Billion Celgene Deal

Industry Insights

In late May, ChinaBio® Group and EBD Group convened the ninth iteration of the ChinaBio® Partnering Forum (see story). This year's event took place against a very positive industry backdrop of rapidly accelerating change -- 34 new funds focused on China life-science funds raised over $15 billion last year and $5.4 billion was invested, three times the previous year's $1.8 billion. In addition, China has taken numerous steps to bring its drug development regulations in line with global practices, a "sea change" that will speed up approvals of novel drugs. The ninth CBPF, which took place in Zhuhai, China, hosted 858 attendees representing 460 companies from 30 countries. It featured over 50 company presentations, and the attendees scheduled a record-breaking 1,682 meetings from over 6,800 requests. 

1 2 3
View single page >> |

Disclosure: None

How did you like this article? Let us know so we can better customize your reading experience. Users' ratings are only visible to themselves.

Comments

Leave a comment to automatically be entered into our contest to win a free Echo Show.